White label – Pompe disease - ClinicalTrials.eu

Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
- Mitomycin
- Gemcitabine Hydrochloride
+1
Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

Not recruiting

3 1
Investigated Diseases:
- Myasthenia gravis
Investigated Drugs:
- Gefurulimab
+3
Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Not recruiting

3 1 1
Investigated Drugs:
- Semaglutide
+12
Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Not recruiting

2 1 1
Investigated Diseases:
- Relapsing multiple sclerosis
Investigated Drugs:
- Ly3541860
- Meglumine Gadoterate
+1
Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic myeloid leukaemia
Investigated Drugs:
+9
Study on the Effectiveness and Safety of Oral Midazolam for Elderly Patients with Severe Neurocognitive Disorders and Care Resistance

Not recruiting

2 1 1 1
Investigated Diseases:
- Cognitive disorder
Investigated Drugs:
- Midazolam
Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva

Not recruiting

3 1
Investigated Diseases:
- Fibrodysplasia ossificans progressiva
Investigated Drugs:
- Garetosmab
Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Not recruiting

3 1 1
Investigated Diseases:
- Pneumonia
Investigated Drugs:
+5
Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
+6
Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter’s Syndrome

Not recruiting

1 1 1 1
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies